Cerus Endovascular Overview
- Founded
- 2011
- Status
- Private
- Employees
- 11
- Latest Deal Type
- Series B
- Latest Deal Amount
- $26.4M
- Investors
- 5
Cerus Endovascular General Information
Description
Developer of proprietary interventional neuroradiology devices and delivery systems designed for the treatment of neurovascular diseases. The company's neuroradiology devices and delivery systems are used for the treatment of hemorrhagic strokes and a range of aneurysm morphologies, including unruptured wide-necked bifurcation and bifurcation aneurysms, enabling the interventional neuroradiologists to treat minimally invasive neurovascular diseases, particularly intracranial aneurysms.
Contact Information
Website
www.cerusendo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- 47757 Fremont Boulevard
- Fremont, CA 94538
- United States
+1 (510) 000-0000
Cerus Endovascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 21-Feb-2020 | $26.4M | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Early Stage VC | 21-Jul-2016 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Early Stage VC | 30-Jun-2015 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC | $3M | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 03-May-2013 | $3M | $3M | 00.000 | Completed | Generating Revenue |
Cerus Endovascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Ordinary | 00,000 | 00.000000 | 000.0 | 000.0 | 00 | 000.0 | 0.00 | |
| Ordinary | 33,789 | $0.000065 | $77.35 | $77.35 | 1x | $77.35 | 5.45% | |
| Series A | 140,388 | $0.000065 | $19.53 | $19.53 | 1x | $19.53 | 22.66% |
Cerus Endovascular Executive Team (5)
Cerus Endovascular Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Franklin Berger | Cerus Endovascular | Board Member | 000 0000 |
| John Kilcoyne | Self | Board Member | 000 0000 |
| Paul Brooke | Self | Board Member | 000 0000 |
| Sam Milstein Ph.D | Cerus Endovascular | Chairman & Director | 000 0000 |
| Stephen Griffin Ph.D | Cerus Endovascular | Board Member, Director & President | 000 0000 |
Cerus Endovascular Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCerus Endovascular Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Andover Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Johnston Associates | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Epiphany Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Mid Atlantic Bio Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Spark Impact | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |